Assess the Penumbra System in the Treatment of Acute Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT01429350
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 108 participants
- Sponsor
- Registry
-
NCT01429350
-
- Other papers using this trial's data
- Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01429350. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2020-09-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assess the Penumbra System in the Treatment of Acute Stroke
- Acronym
- THERAPY
- Condition
- Ischemic Stroke
- Intervention (Drug)
- intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
- Intervention (Device)
- Penumbra System
- Lead sponsor
- Penumbra Inc.
Record details
- Record id
cardio:ct-nct01429350- Content hash
cba54a9441ebbee24af92f9f72ae69246cc5ce0ccea3532f4d1185a278ec9300